Replies to post #117452 on Biotech Values

[dewophile]

addendum:

there should be a PR this weekend on BMY's combo study - it's an oral april 2. it may be somewhat overshadowed by VRUS, but BMY actually has SVRs in nulls that are quite impressive and based on clinicaltrials.gov has greatly expanded the trial so they may be looking to fast track approval in nulls if they can confirm the efficacy in a large cohort
just a hunch